Recomendaciones terapéuticas del VII Consenso Clínico de SIBEN para la encefalopatía hipóxico-isquémica neonatal

Abstract

Starting with this issue of NeoReviews, the editorial board has decided to publish a few articles in Spanish every year and make them available online for free. To accomplish this, NeoReviews came to an agreement with SIBEN, the Ibero-American Society of Neonatology, to publish Clinical Consensus statements that the Society works very hard to produce. This collaborative process involves more than 40 neonatologists and neonatal nurses from 12 to 14 countries of the Ibero-American region, who work in various subgroups for approximately 8 to 10 months. Then the whole group meets in person for several hours to finalize the Consensus. Subsequently, 5 leaders write the final document, which is reviewed and approved by all participant members. SIBEN is a not-for-profit public charitable organization (501[c][3]) and is committed to advancing positive change for improving the delivery of neonatal care and neonatal health in Latin America. SIBEN was originally founded in 2003 by a small group of clinicians concerned with the significant discrepancy that exists in neonatal education, health care delivery, and neonatal outcomes in the Latin American region. There are members from every country in the region, totaling over 2,000 physicians and registered nurses. Five neonatologists from different countries constitute the Board of Directors. The Directive Council was recently completed and is formed by professionals from all countries and encompasses all areas of neonatal care (ie, Nursing, Interdiscipline, Family and Community; Research; Follow-up; and all others). During the last 4 to 5 years, "hands-on" educational activities in many areas have been performed. A detailed document and list are available for review at www.siben.net. A painful and regrettable significant discrepancy and inequality exists in neonatal delivery of care and outcomes in the Latin American region. The gap between what is known and clinical practice is huge in some areas. Educational programs of SIBEN are designed to improve neonatal health, safety, and outcomes and promote efficient and cost-effective neonatal health care delivery in vast areas

Applying Qualitative Research to Develop a Guide for Parents of Newborns With Hypoxic-Ischemic Encephalopathy

“…In the first decade of this century, meta-analyses of clinical trials showed that TH, reducing brain temperature by 3-4 C through cooling of the whole body or the head, is a safe and effective intervention to reduce the mortality and disability associated with HIE (Edwards et al, 2010;Jacobs et al, 2007;Shah, 2010;Tagin et al, 2012). Since 2005, TH has been progressively introduced into neonatal units worldwide to become established as the standard treatment for moderateto-severe HIE in the newborn (Azzopardi, 2010;Blanco et al, 2011;Lemus-varela et al, 2016;NICE Interventional Procedure Guidance [IPG347], 2010;Peliowski-Davidovich et al, 2012).…”

Cuidados Integrales De Enfermería en Un Lactante Con Encefalopatía Isquémica Hipóxica Relacionada Con La Asfixia Perinatal

“…La contención sanguínea y de oxígeno en el momento del nacimiento es capaz de acarrear daños en las células del sistema nervioso central, incluso la muerte celular. Segundo, cuando se restaura el flujo sanguíneo en un cerebro lesionado se desencadenan diversos efectos colaterales, pudiendo dañar las células neurales o hasta llevar a la muerte cerebral (2)(3)(4). Según la Organización Mundial de la Salud (OMS), la asfixia perinatal (AP) está entre las tres principales causas de muerte entre los neonatos (5).…”

“…Según la Organización Mundial de la Salud (OMS), la asfixia perinatal (AP) está entre las tres principales causas de muerte entre los neonatos (5). Hasta el 25% de los recién nacidos y el 8% de las muertes de niños menores de 5 años están directamente asociadas a la AP (2). Cada año, de cada 1000 nacidos vivos, tres a cinco presentará AP en el momento del nacimiento, aumentando los riesgos de las secuelas neurológicas (3).…”